Tevogen Bio Holdings Inc. (TVGN)
NASDAQ: TVGN · Real-Time Price · USD
10.94
+0.47 (4.49%)
Jun 8, 2026, 3:18 PM EDT - Market open
Tevogen Bio Holdings Market Cap
Tevogen Bio Holdings has a market cap or net worth of $45.81 million as of June 8, 2026. Its market cap has decreased by -78.89% in one year.
Market Cap
45.81M
Enterprise Value
52.62M
1-Year Change
-78.89%
Ranking
Category
Stock Price
$10.94
Market Cap Chart
Since January 5, 2022, Tevogen Bio Holdings's market cap has decreased from $446.69M to $45.81M, a decrease of -89.74%. That is a compound annual growth rate of -40.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 43.84M | -33.36% |
| Dec 31, 2025 | 65.79M | -63.51% |
| Dec 31, 2024 | 180.30M | 2.42% |
| Dec 29, 2023 | 176.04M | -64.45% |
| Dec 30, 2022 | 495.15M | 10.85% |
| Jan 5, 2022 | 446.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Metagenomi Therapeutics | 48.19M |
| Genenta Science | 48.13M |
| aTyr Pharma | 46.08M |
| Xilio Therapeutics | 46.07M |
| Lantern Pharma | 45.80M |
| Actuate Therapeutics | 44.98M |
| Nutriband | 43.52M |
| Hyperion DeFi | 42.48M |